MENU

DTIL Stock Precision BioSciences (DTIL, $12.2) Moving Average Convergence Divergence (MACD) Histogram turned negative on June 7, 2024

A.I.dvisor
at Tickeron.com
06/08/24
Loading...
DTIL - Precision BioSciences
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $12.2
Daily change: -$0.34 (-2.71%)
Daily volume: 16.9K
Capitalization: $84.5M
Industry: Biotechnology
This is a Bearish indicator signaling DTIL's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 51 similar cases where DTIL's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

DTIL sees MACD Histogram crosses below signal line

DTIL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 14, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 14, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on DTIL as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DTIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DTIL entered a downward trend on November 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for DTIL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

DTIL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.911) is normal, around the industry mean (14.655). P/E Ratio (19.414) is within average values for comparable stocks, (96.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.824). DTIL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.610) is also within normal values, averaging (218.428).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DTIL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DTIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
DTIL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of technology to produce custom, genome-editing enzymes for human health and biological research

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
302 East Pettigrew Street
Phone
+1 919 314-5512
Employees
109
Web
https://www.precisionbiosciences.com